Colchicine-resistant familial Mediterranean fever in a renal transplantation patient: successful treatment with anakinra
- PMID: 25852877
- PMCID: PMC4377770
- DOI: 10.1093/ckj/sft164
Colchicine-resistant familial Mediterranean fever in a renal transplantation patient: successful treatment with anakinra
Figures
Similar articles
-
Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report.BMC Med Genet. 2017 Aug 31;18(1):97. doi: 10.1186/s12881-017-0457-9. BMC Med Genet. 2017. PMID: 28859624 Free PMC article.
-
Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation.Nephrol Dial Transplant. 2009 Feb;24(2):676-8. doi: 10.1093/ndt/gfn646. Epub 2008 Nov 25. Nephrol Dial Transplant. 2009. PMID: 19033248
-
Anakinra induces complete remission of nephrotic syndrome in a patient with familial mediterranean fever and amyloidosis.Nefrologia. 2016;36(1):63-6. doi: 10.1016/j.nefro.2015.06.026. Epub 2015 Sep 26. Nefrologia. 2016. PMID: 26409501 English, Spanish.
-
Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.Eur J Clin Invest. 2013 Dec;43(12):1314-27. doi: 10.1111/eci.12170. Epub 2013 Oct 14. Eur J Clin Invest. 2013. PMID: 24117178 Review.
-
Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.Best Pract Res Clin Rheumatol. 2016 Apr;30(2):296-303. doi: 10.1016/j.berh.2016.09.001. Epub 2016 Sep 21. Best Pract Res Clin Rheumatol. 2016. PMID: 27886801 Review.
Cited by
-
The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.Front Immunol. 2020 May 28;11:971. doi: 10.3389/fimmu.2020.00971. eCollection 2020. Front Immunol. 2020. PMID: 32670263 Free PMC article. Review.
-
Update on the management of colchicine resistant Familial Mediterranean Fever (FMF).Orphanet J Rare Dis. 2019 Oct 15;14(1):224. doi: 10.1186/s13023-019-1201-7. Orphanet J Rare Dis. 2019. PMID: 31615541 Free PMC article. Review.
-
Canakinumab treatment in renal transplant recipients with familial Mediterranean fever.J Nephrol. 2018 Jun;31(3):453-455. doi: 10.1007/s40620-018-0475-5. Epub 2018 Feb 14. J Nephrol. 2018. PMID: 29446001
-
Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature.Front Pharmacol. 2017 May 31;8:342. doi: 10.3389/fphar.2017.00342. eCollection 2017. Front Pharmacol. 2017. PMID: 28620307 Free PMC article.
-
Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.Front Immunol. 2021 Nov 11;12:744780. doi: 10.3389/fimmu.2021.744780. eCollection 2021. Front Immunol. 2021. PMID: 34858402 Free PMC article. Review.
References
-
- Tuglular S, Yalcinkaya F, Paydas S, et al. A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant. 2002;17:2003–2005. - PubMed
-
- Ben-Chetrit E, Ozdogan H. Non-response to colchicine in FMF—definition, causes and suggested solutions. Clin Exp Rheumatol. 2008;26(Suppl 50):S49–S51. - PubMed
-
- Seyahi E, Ozdogan H, Celik S, et al. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clin Exp Rheumatol. 2006;24(Suppl 42):S99–103. - PubMed
-
- Baykal Y, Saglam K, Yilmaz MI, et al. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol. 2003;22:99–101. - PubMed
-
- Alpay N, Sumnu A, Calışkan Y, et al. Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever. Rheumatol Int. 2012;32:3277–3279. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources